Related references
Note: Only part of the references are listed.Phase IV Trial of Miltefosine in Adults and Children for Treatment of Visceral Leishmaniasis (Kala-Azar) in Bangladesh
Mahmudur Rahman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2011)
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
Shyam Sundar et al.
LANCET (2011)
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Shyam Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
New treatment approach in Indian visceral leishmaniasis: Single-dose liposomal amphotericin B followed by short-course oral miltefosine
Shyam Sundar et al.
CLINICAL INFECTIOUS DISEASES (2008)
Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal - the challenges for diagnosis and treatment
Shyam Sundar et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis
Sujit Kumar Bhattacharya et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection
K Ritmeijer et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mechanisms of experimental resistance of Leishmania to miltefosine:: Implications for clinical use
F. Javier Perez-Victoria et al.
DRUG RESISTANCE UPDATES (2006)
Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India
SK Bhattacharya et al.
CLINICAL INFECTIOUS DISEASES (2004)
Miltefosine for New World cutaneous leishmaniasis
J Soto et al.
CLINICAL INFECTIOUS DISEASES (2004)
Oral miltefosine for Indian visceral leishmaniasis
S Sundar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
